Ledipasvir/sofosbuvir for 12 or 24 weeks in HCV genotype 1 in HIV/HCV co-infected subjects with compensated liver disease: real-world experience from the MADRID-CoRe studyJuan Berenguer,Ana Moreno,Luz Martin-Carbonero,Lourdes Dominguez,Teresa Aldamiz-Echevarria,Angela Gil-Martin,Encarnacion Cruz-Martos,Jorge Vergas,Ignacio Santos,Laura Benitez, Julio De Miguel,Jesus Troya,Beatriz Alvarez-Alvarez,Rafael Torres, Eduardo Canalejo,Sari Arponen, Maria Teresa de Guzman,Luis Gotuzzo,Maria Jose Calvo,Marta Alcaraz,Inmaculada Jarrin,Juan Gonzalez-GarciaJOURNAL OF THE INTERNATIONAL AIDS SOCIETY(2016)引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要